ResMed Inc (RMD)
238.96
+4.22
(+1.80%)
USD |
NYSE |
Nov 18, 15:21
ResMed Price: 238.96 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 232.13 | 235.09 | 231.17 | 234.74 | 1.115M |
| Nov 14, 2024 | 235.44 | 236.89 | 231.18 | 231.43 | 1.102M |
| Nov 13, 2024 | 246.41 | 247.73 | 235.36 | 235.44 | 993990.0 |
| Nov 12, 2024 | 248.81 | 249.26 | 246.18 | 247.21 | 737144.0 |
| Nov 11, 2024 | 252.55 | 252.99 | 248.43 | 248.69 | 898839.0 |
| Nov 08, 2024 | 249.00 | 255.16 | 248.52 | 252.38 | 930321.0 |
| Nov 07, 2024 | 246.48 | 248.55 | 243.62 | 248.54 | 815815.0 |
| Nov 06, 2024 | 248.74 | 250.00 | 241.98 | 245.63 | 802462.0 |
| Nov 05, 2024 | 243.61 | 246.51 | 241.28 | 245.74 | 1.081M |
| Nov 04, 2024 | 245.00 | 247.75 | 242.84 | 243.61 | 1.236M |
| Nov 01, 2024 | 242.00 | 246.77 | 241.12 | 244.28 | 1.118M |
| Oct 31, 2024 | 242.00 | 243.67 | 240.53 | 242.47 | 1.166M |
| Oct 30, 2024 | 243.30 | 245.84 | 241.06 | 243.02 | 1.105M |
| Oct 29, 2024 | 247.62 | 250.08 | 243.83 | 244.40 | 1.486M |
| Oct 28, 2024 | 258.00 | 259.33 | 246.27 | 246.83 | 1.796M |
| Oct 25, 2024 | 260.00 | 260.49 | 252.80 | 256.07 | 3.517M |
| Oct 24, 2024 | 237.46 | 243.99 | 237.46 | 239.05 | 1.846M |
| Oct 23, 2024 | 239.13 | 240.22 | 235.08 | 237.40 | 1.020M |
| Oct 22, 2024 | 239.06 | 241.17 | 237.63 | 239.98 | 614629.0 |
| Oct 21, 2024 | 241.06 | 242.44 | 238.40 | 240.05 | 973032.0 |
| Oct 18, 2024 | 240.60 | 241.67 | 237.78 | 240.00 | 766425.0 |
| Oct 17, 2024 | 239.78 | 242.15 | 237.37 | 239.59 | 839334.0 |
| Oct 16, 2024 | 238.19 | 242.11 | 237.45 | 238.34 | 816001.0 |
| Oct 15, 2024 | 242.37 | 243.99 | 238.73 | 239.18 | 1.025M |
| Oct 14, 2024 | 240.12 | 242.23 | 238.68 | 240.71 | 588166.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
114.34
Minimum
Mar 20 2020
297.36
Maximum
Sep 08 2021
206.94
Average
210.89
Median
Apr 26 2021
Price Benchmarks
| Boston Scientific Corp | 90.86 |
| Globus Medical Inc | 82.17 |
| Abbott Laboratories | 117.44 |
| Haemonetics Corp | 88.37 |
| Becton Dickinson & Co | 224.28 |
Price Related Metrics
| PE Ratio | 31.65 |
| PS Ratio | 7.333 |
| PEG Ratio | 1.403 |
| Price to Book Value | 6.752 |
| Price to Free Cash Flow | 26.17 |
| Earnings Yield | 3.16% |
| Market Cap | 35.08B |
| PEGY Ratio | 1.351 |
| Operating PE Ratio | 23.78 |
| Normalized PE Ratio | 30.15 |